{"id":"W4380729666","doi":"10.1093/ecco-jcc/jjad100","title":"Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; McMaster University; Population Health Research Institute; Western University","funders":"UCB Pharma; Allergan; Genentech; ActoGeniX; Celltrion; Teva Pharmaceutical Industries; Gilead Sciences; Mylan; Celgene; Biogen; GlaxoSmithKline; Takeda Oncology; Tillotts Pharma; Amgen; Dr. Falk Pharma; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Relative risk; Placebo; Gastroenterology; Ulcerative colitis; Inflammatory bowel disease; Meta-analysis; Randomized controlled trial; Crohn's disease; Clinical trial; Confidence interval; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01163761,0.002467509,0.01847015,0.005372749,0.0005111363,0.002604521,0.001886591,0.001829681,0.004077304],"category_scores_gemma":[0.02449983,0.001247794,0.03271435,0.006889618,0.0006916081,0.001443243,0.001240813,0.001629523,0.0003058369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002276788,"about_ca_system_score_gemma":0.002744152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005815387,"about_ca_topic_score_gemma":0.01345876,"domain_scores_codex":[0.9917365,0.004187644,0.002134003,0.0007750261,0.0009268976,0.0002400102],"domain_scores_gemma":[0.9840119,0.01165094,0.002715085,0.0003915922,0.001023081,0.0002074001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002217157,0.00002541224,0.002533194,0.4335649,0.5493674,0.00009142374,0.00005931336,0.000547955,0.0001754011,0.0001078576,0.0006366746,0.01067335],"study_design_scores_gemma":[0.000759982,0.0002092984,0.002666258,0.0253051,0.9692498,0.00008125274,0.00003081278,0.0001733846,0.00009191876,0.0001290512,0.001285277,0.00001783286],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003476268,0.9951701,0.0002952341,0.0001345618,0.00009370884,0.0002060031,0.0004078533,0.00001594668,0.0002004249],"genre_scores_gemma":[0.1354016,0.8599812,0.00162418,0.0007178554,0.0002328499,0.0009543333,0.0007568299,0.00001982186,0.0003113227],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01847015,"threshold_uncertainty_score":0.06154633,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0320333354844749,"score_gpt":0.3136903146730268,"score_spread":0.2816569791885519,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}